BioMarin appointed Robert Plenge to its board and granted him 6,140 restricted stock units valued at $400,000. The award will vest immediately before the company’s next regular annual meeting, while his committee appointment and standard director fees define the stated terms for investors.

Key Highlights

  • Robert Plenge will receive standard fees for non-employee directors and committee service.
  • The $400,000 restricted stock unit award will vest immediately before BioMarin’s next regular annual meeting.
  • The board said Plenge’s appointment involved no arrangement and no reportable related-party transaction.

$400,000 Equity Award Under 2017 Plan

Plenge joined the Science and Technology Committee. The restricted stock unit grant was valued at $400,000 and issued under BioMarin (NASDAQ: BMRN)’s amended 2017 Equity Incentive Plan. The units will vest immediately before the next regular annual meeting of stockholders, matching the vesting date for the 2026 annual award made to other non-employee directors.

Independent Director Adds Committee Role

Plenge was appointed as an independent, non-employee director. The board also said his selection was not made under an arrangement or understanding with another person and that he had no reportable related-party transaction.